| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-05 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.2 | 6e-05 |